Top Companies To Own In Right Now

With the increasing likelihood of a U.S.-led military intervention in Syria, the oil markets have become volatile. Brent prices rose to as high as $117 a barrel last week. The price strength also�might be attributed to ongoing supply disruptions in Libya. The energy strategy team at UBS believes that if military action is taken in Syria, it will be short-lived, and that Libya outages are temporary. Barring escalation of the Syrian conflict to other regions in the Middle East, they expect no prolonged effects in the oil markets.

In a special report for investors, UBS has highlighted top names to buy that can either benefit from the current situation, or at the very least will be affected less than some of the other major firms. Here are the stocks to buy now, broken out by sector with analysis.

Integrated Major Oils

The UBS team expects the large integrated oil companies to benefit from the increase in oil pricing, even if it is temporary. Their concern would be for those with operations in and around the Middle East and Russia, should the conflict spread.

Top Solar Companies To Invest In Right Now: Medidata Solutions Inc.(MDSO)

Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. Its solutions comprise software and services that allow customers to increase the value of their development programs by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. The company primarily offers Medidata Rave, a comprehensive platform for capturing and managing clinical data. It also provides Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a protocol development tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a busi ness analytics platform; and Medidata Balance, a randomization and trial supply management solution, which streamlines the process of developing, building, and implementing subject allocation plans. In addition, the company offers Medidata Grants Manager, an application to benchmark the investigator budgets against industry data; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. Further, it provides hosting, support, and professional services. The company serves pharmaceutical, biotechnology, and medical device companies; academic institutions; and CROs and other entities engaged in clinical trials through a direct sales force; and through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Brian Pacampara]

  What: Shares of cloud-based clinical development technologist Medidata Solutions (NASDAQ: MDSO  ) surged 19% today after its quarterly results and outlook topped Wall Street expectations.�

• [By Kevin Marder]

  Among the names, Medidata Solutions (MDSO) is a developer of clinical development software for use in the research of new medical treatments. Most Wall Street analysts forecast earnings growth of 38% in 2013 and 13% in 2014. Revenue growth over the past several quarters has been very steady, at 21%, 24%, 26%, 27% and 27%, respectively.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Medidata Solutions (NASDAQ: MDSO) were 19.89 percent to $42.21 after the company reported downbeat quarterly results.

• [By Ben Levisohn]

  The iShares Russell 2000 ETF (IWM) has dropped 5.2% so far this year, while Mueller Industries (MLI), which has plunged 55%, Medidata Solutions (MDSO), which has plummeted 44%, Financial Engines (FNGN), which has slid 42%, and Isis Pharmaceuticals (ISIS), which has tumbled 42%, are the index’s biggest losers.

Top Companies To Own In Right Now: GasLog Ltd (GLOG)

GasLog Ltd. (GasLog), incorporated on July 16, 2003, is an owner, operator and manager of liquefied natural gas (LNG) carriers. The Company is a holding company. Its subsidiaries conduct all of its operations and own all of its operating assets, including its ships. The Company operates in two segments: vessel ownership and vessel management. In the vessel ownership segment, the services provided primarily consist of chartering out company-owned LNG carriers, and in the vessel management segment the services provided consist of LNG carrier technical management services, as well as LNG carrier construction supervision services and other vessel management services provided to the Company�� vessel ownership segment and to external third parties.

In February 2011, GasLog Carriers Ltd. established two vessel-owning companies, GAS-five Ltd. and GAS-six Ltd. In March 2011, GasLog Carriers Ltd. established two vessel-owning companies, GAS-seven Ltd. and GAS-eight Ltd. In June 2011, GasLog Carriers Ltd. established two additional vessel-owning companies, GAS-nine Ltd. and GAS-ten Ltd. In June 2011, Ceres Shipping Ltd. (Ceres Shipping) transferred its interest in GasLog Ltd. to Blenheim Holdings Ltd. (Blenheim Holdings). In June 2011, an entity jointly owned by the Livanos and Radziwill families (Joint Venture Partner) sold its 49% interest in GAS-three Ltd., GAS-four Ltd., GAS-five Ltd. and GAS-six Ltd. to Ceres Shipping. Ceres Shipping contributed the 49% interest in GAS-three Ltd., GAS-four Ltd., GAS-five Ltd. and GAS-six Ltd. to Blenheim Holdings, who in turn contributed the 49% interest in these four vessel-owning companies to GasLog Ltd., which contributed the same to GasLog Carriers Ltd. As of December 31, 2011, the Company owned 100% interest in GAS-three Ltd., GAS-four Ltd., GAS-five Ltd. and GAS-six Ltd. On July 11, 2011 and September 5, 2011, the Company transferred its interest of two dormant subsidiaries, GasLog Holdings Limited and GasLog Services Limited, respectively, to Ceres Shi! pping.

As of December 31, 2011, the Company�� owned fleet consisted of 10 wholly owned LNG carriers. As of December 31, 2011, the Company managed and operated 14 LNG carriers, which included its owned ships, as well as 11 ships owned or leased by BG Group plc (BG Group), a participant in the worldwide energy and natural gas markets, and one additional LNG carrier in which it had a 25% interest. As of December 31, 2011, the Company owned a 25% interest in Egypt LNG Shipping Ltd. (Egypt LNG), whose principal asset is the LNG carrier Methane Nile Eagle. The Company�� owned fleet includes the GasLog Savannah, the GasLog Singapore, four LNG carriers on order at Samsung Heavy Industries Co., Ltd. (Samsung Heavy Industries) in South Korea, two LNG carriers on order at Samsung Heavy Industries in South Korea, and two LNG carriers on order at Samsung Heavy Industries in South Korea.

The Company�� wholly owned subsidiary, GasLog LNG Services Ltd., (GasLog LNG Services) handles the technical management of its fleet. Through GasLog LNG Services, it provides technical ship management services for 12 LNG carriers owned by third parties in addition to management of the two LNG carriers operating in its owned fleet. The Company provides the services of its owned ships under time charters. The Company�� subsidiaries include GasLog Investments Ltd., GasLog Monaco S.A.M., Ceres LNG Employee Incentive Scheme Ltd., GasLog Carriers Ltd., GAS-one Ltd., GAS-two Ltd., GAS-three Ltd., GAS-four Ltd., GasLog Shipping Company Ltd., GasLog Shipping Limited and Egypt LNG Shipping Ltd.

Advisors' Opinion:

• [By Stephen Quickel]

  Gaslog Limited (GLOG)

  This Monaco-based company owns and operates a sizeable fleet of ocean-going liquefied natural gas (LNG) carriers, which it charters out and manages for others. Earnings are expected to grow 32% a year. Thirteen of 14 analysts rate it a Strong Buy or Buy.

• [By Jan-e- Alam]

  GasLog (NYSE: GLOG  ) shares have come under pressure recently, as the news of the recent transaction between Teekay LNG Partners (NYSE: TGP  ) and BG Group (NASDAQOTH: BRGYY  ) raised growth concerns among investors. I will get to the details of the transaction and why I think the deal was not for GasLog later, but let's first take a look at GasLog and why I think the company stands to benefit from the liquefied natural gas (LNG) boom.

Top Companies To Own In Right Now: First Niagara Financial Group Inc.(FNFG)

First Niagara Financial Group, Inc. operates as the holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses. It offers retail deposit accounts, which include savings, negotiable order of withdrawal, checking, money market, and certificate of deposit accounts, as well as provides business savings and checking, money market, cash management accounts, and municipal deposit accounts. The company?s loan portfolio comprises commercial real estate and multi-family loans; commercial business loans; residential real estate loans; home equity loans; and consumer loans consisting of indirect mobile home loans, and personal secured and unsecured loans. It also sells insurance products, including commercial and personal insurance, surety bond, life, disability, and long-term care coverage products. In addition, the company offers risk management consulting services comprising altern ative risk and self-insurance services, claims investigation and adjusting services, and third party administration services for self insured workers? compensation plans. Further, it provides employee benefits plan and compensation consulting services. Additionally, First Niagara Financial Group offers wealth management services that manage client funds utilizing various third party investment vehicles consisting of stocks, bonds, mutual funds, and annuities, as well as other investment products, such as individual retirement accounts, education savings plans, and retirement plans. As of December 31, 2010 it operated 257 bank branches, including 115 in Upstate New York and 142 branches in Pennsylvania. The company was founded in 1870 and is based in Buffalo, New York.

Advisors' Opinion:

• [By Eric Volkman]

  First Niagara Financial (NASDAQ: FNFG  ) will return money to two separate classes of its stockholders. The company has declared quarterly dividends for its common shares and its class B preferreds, both of which will be paid on May 15 to shareholders of record as of May 3.

• [By Monica Gerson]

  First Niagara Financial Group (NASDAQ: FNFG) is projected to report its Q3 earnings at $0.19 per share on revenue of $365.77 million.

  Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top Companies To Own In Right Now: Atlantic Power Corp (AT)

Atlantic Power Corporation (Atlantic Power) owns and operates a fleet of power generation and infrastructure assets in the United States and Canada. The Company�� power generation projects sell electricity to utilities and industrial customers under long-term power purchase agreements. During the year ended December 31, 2011, its power generation projects in operation had an aggregate gross electric generation capacity of approximately 3,397 megawatts in which its ownership interest was approximately 2,140 megawatts. The Company operates in five segments: Northeast, Southeast, Northwest, Southwest and Un-allocated Corporate. As of December 31, 2011, its portfolio consisted of interests in 31 operational power generation projects across 11 states in the United States and two provinces in Canada, and a 53 megawatts biomass project under construction in Georgia and a 500-kilovolt 84-mile electric transmission line. On December 31, 2012, the Company acquired Ridgeline Energy Holdings, Inc. Advisors' Opinion:

• [By Justin Loiseau]

  Mr. Market seems to have approved of the move: Exelon stock is up 18% for Q1, an amazing turnaround after nearly five years of plummeting prices. Atlantic Power (NYSE: AT  ) hasn't been as lucky with its own dividend division. Even though the utility announced a 66% haircut last quarter for many of the same reasons as Exelon, its stock is down 60% over the last three months.

• [By Justin Loiseau]

  While Atlantic Power (NYSE: AT  ) has its own issues as a dividend stock, it, too, will benefit from Obama's latest plans. The "growth by acquisition" corporation recently revealed big plans to head into renewables, and wind already accounts for almost one-fifth of its total capacity.

• [By Justin Loiseau]

  AGL and Integrys aren't the only utilities switching around subsidiaries. Duke Energy (NYSE: DUK  ) completed its purchase of a 72% stake in Atlantic Power's (NYSE: AT  ) Path 15 transmission project. The 84-mile line connects Northern and Southern California's transmission grids and, according to Duke, plays "a key role in maintaining statewide electric system reliability and market efficiency."

• [By Justin Loiseau]

  Atlantic Power (NYSE: AT  ) isn't going to win any economies-of-scale awards, but the utility is determined to ramp up investments in renewables over the next few years. In 2012, Atlantic added three wind farms with 150 net MW to its assets via a subsidiary acquisition from Veolia Environnement.

Top Companies To Own In Right Now: Medical Marijuana Inc (MJNA.PK)

Medical Marijuana Inc. (MJNA), incorporated on May 23, 2005, is the publicly held company vested in the medical marijuana and industrial hemp markets. The Company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. In March 2013, it sold certain equipment and inventory, web domain names, phone numbers, and all existing and pending agreements with hemp production and processing facilities to CannaVEST Corp.

The Company�� services are varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 50 and patented cannabinoid delivery methods that are more socially and medically acceptable than smoking.

Advisors' Opinion:

• [By Alan Brochstein]

  Taking into account all of the data I have shared, I want to introduce my take on the most important names to follow. My initial list takes into account not only the market cap, but also business model and interest level. These are the stocks that I think merit the most attention (in alphabetical order):

  CannaVest (CANV.OB)GW Pharma (GWPH)MedBox (MDBX.PK)Medical Marijuana, Inc. (MJNA.PK)

  CANV doesn't really trade, as it is held closely by insiders (99.7%, including MJNA). I have a few concerns, including the valuation and some near-term financial challenges typical of a start-up with just one client looking to expand its customer base, but I like the focus and the fact that it is an SEC filer with a relatively clean history (i.e. none of the baggage of some of these other companies). I have spoken to its outsourced CFO and am impressed by his background (has been CFO or held key financial roles at publicly-traded healthcare companies). CANV is the partner to MJNA that is responsible for manufacturing the CBD (Cannibidiol, the cannabinoid in marijuana that is increasingly viewed as offering substantial medical benefits). I am very concerned about the near-term financials, but this is a pure-play with probably a two-year lead over other companies. I don't see a moat in terms of intellectual property or brands, but they have a good lead in terms of sourcing of supply and penetration into potential customers. Quite simply, they don't appear to have competition at present. The company, then, is a call option on CBD demand taking off. It appears that it could be a supplier to even Big Pharma should medical marijuana research move into the mainstream.